ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,923Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 625

$935K Total Retail Price of All Prescriptions

Rank: 34 out of 625

575 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 575 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 9,118 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 1,095 642 1 1
LISINOPRIL 1,058 524 2 5
LEVOTHYROXINE SODIUM 646 293 3 3
SIMVASTATIN 632 360 4 2
RANITIDINE HCL 567 269 5 25
PRAVASTATIN SODIUM 552 305 6 8
OMEPRAZOLE 495 196 7 6
METOPROLOL TARTRATE 457 233 8 11
FUROSEMIDE 450 212 9 7
METFORMIN HCL ER 446 279 10 41
TRAMADOL HCL 404 183 11 16
GLIPIZIDE XL 354 262 12 83
SPIRONOLACTONE 351 163 13 64
POTASSIUM CHLORIDE 314 191 14 19
ATORVASTATIN CALCIUM 283 152 15 9
DIOVAN 242 171 16 28
HYDROCODONE-ACETAMINOPHEN 214 86 S3 17 4
ALLOPURINOL 208 95 18 29
PROAIR HFA 204 71 19 57
CARVEDILOL 202 112 20 23
GABAPENTIN 202 50 20 14
CYCLOBENZAPRINE HCL 197 38 R 22 65
TRAZODONE HCL 188 81 23 51
JANUVIA 186 115 24 74
FLUOXETINE HCL 182 98 25 62
LANTUS 168 69 26 54
AMITRIPTYLINE HCL 159 53 R 27 61
GLIPIZIDE ER 151 101 28 68
MELOXICAM 148 85 29 31
ATENOLOL 147 96 30 22
VENTOLIN HFA 144 62 31 93
DOXAZOSIN MESYLATE 139 97 32 88
VERAPAMIL ER 139 80 32 103
ISOSORBIDE MONONITRATE ER 137 89 34 49
PREMARIN 137 55 R 34 105
CLOPIDOGREL 135 67 36 30
PLAVIX 133 73 37 43
ADVAIR DISKUS 132 61 38 63
HYDROCHLOROTHIAZIDE 126 61 39 12
LIPITOR 119 48 40 75
TRIAMTERENE-HYDROCHLOROTHIAZID 115 61 41 174
PROMETHAZINE HCL 110 23 R 42 84
LYRICA 108 60 43 71
SERTRALINE HCL 107 57 44 26
NEXIUM 106 45 45 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 49 46 27
METOPROLOL SUCCINATE 103 61 46 15
BACLOFEN 103 26 46 138
GEMFIBROZIL 102 58 49 127
JANUMET 99 26 50 163
WARFARIN SODIUM 98 58 51 20
POLYETHYLENE GLYCOL 3350 97 21 52 82
PHENYTOIN SODIUM EXTENDED 93 41 53 119
ZOLPIDEM TARTRATE 89 36 54 13
NAPROXEN 89 0 54 104
INSULIN SYRINGE 87 27 56 77
ACTOS 87 46 56 102
FLUTICASONE PROPIONATE 84 41 58 32
CYMBALTA 83 42 59 46
DIGOXIN 83 53 59 55
PEN NEEDLE 79 39 61 100
ALENDRONATE SODIUM 75 65 62 34
AZITHROMYCIN 74 23 63 40
INDAPAMIDE 67 51 64 158
COLCRYS 65 35 65 117
CLONIDINE HCL 64 49 66 50
BENAZEPRIL HCL 63 26 67 35
ESTRADIOL 63 40 R 67 128
CIPROFLOXACIN HCL 62 43 69 60
CITALOPRAM HBR 59 37 70 24
NITROSTAT 58 23 71 202
KLOR-CON M20 57 25 72 47
QUINAPRIL HCL 56 31 73 136
METOCLOPRAMIDE HCL 56 0 73 133
MECLIZINE HCL 55 30 75 113
LOSARTAN POTASSIUM 55 22 75 18
NOVOLOG FLEXPEN 55 17 75 151
HYDRALAZINE HCL 53 31 78 80
METOLAZONE 53 0 78 240
CRESTOR 53 13 78 17
SUCRALFATE 53 11 78 186
VENLAFAXINE HCL ER 52 38 82 86
SPIRIVA 52 27 82 70
NOVOLOG 51 0 84 112
PAROXETINE HCL 50 13 85 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.